These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38484340)

  • 1. Clinical characteristics and risk factors for Klebsiella pneumoniae bloodstream infection in 152 immunocompetent patients.
    Zhang Q; Wang P; Shen M; Shan C
    J Infect Dev Ctries; 2024 Feb; 18(2):219-226. PubMed ID: 38484340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection.
    Tsay RW; Siu LK; Fung CP; Chang FY
    Arch Intern Med; 2002 May; 162(9):1021-7. PubMed ID: 11996612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection.
    Cheng J; Li Q; Zhang G; Xu H; Li Y; Tian X; Chen D; Luo Z
    BMC Pediatr; 2022 Oct; 22(1):568. PubMed ID: 36192715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan.
    Chen CL; Hou PC; Wang YT; Lee HY; Zhou YL; Wu TS; Janapatla RP; Yang CC
    J Infect Dev Ctries; 2020 Apr; 14(4):373-379. PubMed ID: 32379714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
    Li J; Ren J; Wang W; Wang G; Gu G; Wu X; Wang Y; Huang M; Li J
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):679-689. PubMed ID: 29238932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.
    Chen J; Li J; Huang F; Fang J; Cao Y; Zhang K; Zhou H; Cai J; Cui W; Chen C; Zhang G
    BMC Pulm Med; 2023 Mar; 23(1):102. PubMed ID: 36978069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to positivity of Klebsiella pneumoniae in blood culture as prognostic indicator for pediatric bloodstream infections.
    Cheng J; Zhang G; Li Q; Xu H; Yu Q; Yi Q; Luo S; Li Y; Tian X; Chen D; Luo Z
    Eur J Pediatr; 2020 Nov; 179(11):1689-1698. PubMed ID: 32394266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients.
    Tsai SS; Huang JC; Chen ST; Sun JH; Wang CC; Lin SF; Hsu BR; Lin JD; Huang SY; Huang YY
    Chang Gung Med J; 2010; 33(5):532-9. PubMed ID: 20979704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
    Harada S; Aoki K; Yamamoto S; Ishii Y; Sekiya N; Kurai H; Furukawa K; Doi A; Tochitani K; Kubo K; Yamaguchi Y; Narita M; Kamiyama S; Suzuki J; Fukuchi T; Gu Y; Okinaka K; Shiiki S; Hayakawa K; Tachikawa N; Kasahara K; Nakamura T; Yokota K; Komatsu M; Takamiya M; Tateda K; Doi Y
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for in-hospital mortality in patients with type 2 diabetes complicated by community-acquired Klebsiella pneumoniae bacteremia.
    Huang CH; Tsai JS; Chen IW; Hsu BR; Huang MJ; Huang YY
    J Formos Med Assoc; 2015 Oct; 114(10):916-22. PubMed ID: 26315482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.
    Anderson DJ; Engemann JJ; Harrell LJ; Carmeli Y; Reller LB; Kaye KS
    Antimicrob Agents Chemother; 2006 May; 50(5):1715-20. PubMed ID: 16641440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
    Marra AR; Wey SB; Castelo A; Gales AC; Cal RG; Filho JR; Edmond MB; Pereira CA
    BMC Infect Dis; 2006 Feb; 6():24. PubMed ID: 16478537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is early time to positivity of blood culture associated with clinical prognosis in patients with
    Hou W; Han T; Qu G; Sun Y; Yang D; Lin Y
    Epidemiol Infect; 2023 Feb; 151():e43. PubMed ID: 36805070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial
    Juan CH; Chuang C; Chen CH; Li L; Lin YT
    Antimicrob Resist Infect Control; 2019; 8():1. PubMed ID: 30622702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae.
    Christodoulou S; Kyriazopoulou E; Chrysanthakopoulou M; Karlis G; Karampela I; Gkizeli K; Veliki N; Safarika A; Giamarellos-Bourboulis EJ; Adamis G;
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2171-2177. PubMed ID: 28639164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong.
    Man MY; Shum HP; Chan YH; Chan KC; Yan WW; Lee RA; Lau SKP
    J Hosp Infect; 2017 Sep; 97(1):35-41. PubMed ID: 28602703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.